Novel Cytotoxic T-Lymphocyte Escape Mutation by a Three-Amino-Acid Insertion in the Human Immunodeficiency Virus Type 1 p6 Pol and p6 Gag Late Domain Associated with Drug Resistance
- 1 January 2008
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 82 (1) , 495-502
- https://doi.org/10.1128/jvi.01096-07
Abstract
Cytolytic T lymphocytes (CTL) play a major role in controlling human immunodeficiency virus type 1 (HIV-1) infection. To evade immune pressure, HIV-1 is selected at targeted CTL epitopes, which may consequentially alter viral replication fitness. In our longitudinal investigations of the interplay between T-cell immunity and viral evolution following acute HIV-1 infection, we observed in a treatment-naïve patient the emergence of highly avid, gamma interferon-secreting, CD8 + CTL recognizing an HLA-Cw*0102-restricted epitope, NSPTRREL (NL8). This epitope lies in the p6 Pol protein, located in the transframe region of the Gag-Pol polyprotein. Over the course of infection, an unusual viral escape mutation arose within the p6 Pol epitope through insertion of a 3-amino-acid repeat, NSPT(SPT)RREL, with a concomitant insertion in the p6 Gag late domain, PTAPP(APP). Interestingly, this p6 Pol insertion mutation is often selected in viruses with the emergence of antiretroviral drug resistance, while the p6 Gag late-domain PTAPP motif binds Tsg101 to permit viral budding. These results are the first to demonstrate viral evasion of immune pressure by amino acid insertions. Moreover, this escape mutation represents a novel mechanism whereby HIV-1 can alter its sequence within both the Gag and Pol proteins with potential functional consequences for viral replication and budding.Keywords
This publication has 52 references indexed in Scilit:
- Evolution of Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitopes: Fitness-Balanced EscapeJournal of Virology, 2007
- HIV-1 protease and reverse transcriptase mutations for drug resistance surveillanceAIDS, 2007
- Rapid Reversion of Sequence Polymorphisms Dominates Early Human Immunodeficiency Virus Type 1 EvolutionJournal of Virology, 2007
- Selection on the Human Immunodeficiency Virus Type 1 Proteome following Primary InfectionJournal of Virology, 2006
- The pigtail macaque MHC class I allele Mane‐A*10 presents an immundominant SIV Gag epitope: identification, tetramer development and implications of immune escape and reversionJournal of Medical Primatology, 2005
- Gag-p6 Tsg101 Binding Site Duplications in Maternal–Infant HIV InfectionAIDS Research and Human Retroviruses, 2005
- A Dominant Role for CD8+-T-Lymphocyte Selection in Simian Immunodeficiency Virus Sequence VariationJournal of Virology, 2004
- Analysis of Insertions and Deletions in the gag p6 Region of Diverse HIV Type 1 StrainsAIDS Research and Human Retroviruses, 2004
- The Dimer Interfaces of Protease and Extra-Protease Domains Influence the Activation of Protease and the Specificity of GagPol CleavageJournal of Virology, 2003
- Resistance to Nucleoside Analog Reverse Transcriptase Inhibitors Mediated by Human Immunodeficiency Virus Type 1 p6 ProteinJournal of Virology, 2001